New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

National Institutes of Health to Fund Research Probing Proteins Linked to Cancer, Diabetes

June 20, 2013
375

Researchers from the Polytechnic Institute of New York University (NYU-Poly) and NYU have received a grant from the National Institutes of Health (NIH) to further a novel approach to understanding the genetic underpinnings of diseases, including cancer and diabetes.

The NIH grant will provide $1.2 million over four years.

Jin Kim Montclare, an associate professor of chemical and molecular engineering at NYU-Poly, and Yingkai Zhang, an associate professor of chemistry at NYU, have teamed to study the functioning of histone—one of the key proteins in human DNA. Histones are scaffolding proteins that organize DNA within the cell nucleus, and they are subject to modifications by enzymes that affect gene expression, both in health and disease.

Zhang and Montclare are combining their expertise in computational chemistry and protein engineering, respectively, to shed new light on one of the key enzymes that modify histones, histone acetyltransferases (HATs).

“HATs play an essential role in gene regulation, and while we know that aberrant or mutated HATs are associated with diseases like cancer and diabetes, we don’t understand their precise catalytic mechanisms,” explained Montclare. “If we can understand the processes by which these proteins can modify histones and how mutations can lead to disease, we move closer to creating targeted therapies to prevent or reverse these changes.”

The researchers’ collaborative approach is unique and has not been explored for HATs. Zhang will create a computational study of the mechanics of HATs, offering what may be the most detailed picture of their workings. This sets the stage for Montclare’s work—engineering and testing the HATs and designed variants for reactivity on histones.

“Bringing computational powers to bear on these processes will not only elucidate the underpinnings of the enzymes as they exist now, but will allow us to run simulations to test the impact of modifications and therapies to reverse the kinds of changes linked to disease,” Zhang said.

This Press Release is in the following Topics:
Arts and Science, Research, Polytechnic School of Engineering

Type: Press Release

Press Contact: James Devitt | (212) 998-6808

National Institutes of Health to Fund Research Probing Proteins Linked to Cancer, Diabetes

Search News



NYU In the News

Entrepreneurship Lab Opens at NYU

Crain’s New York Business covered the opening of the Mark and Debra Leslie Entrepreneurial eLab, which will be the headquarters for NYU’s Entrepreneurial Institute and all of the University’s programs aimed at promoting innovation and startups.

A Globalizer for N.Y.U. in Abu Dhabi

The New York Times profiled Bill Bragin who will become the first executive artistic director of NYU Abu Dhabi’s new performing arts center.

Think Tank to Ponder a Future for Ballet

The New York Times profiled Jennifer Homans, the director of NYU’s new Center for Ballet and the Arts.

The Brilliant Ten: Jonathan Viventi Builds Devices That Decode Thoughts

Popular Science named Assistant Bioengineering Professor Jonathan Viventi as one of its “brilliant ten” for his research into brain implants that could one day halt epileptic episodes:

Living and Leaving the Dream: Adrian Cardenas’ Journey from the Major Leagues to College

The New York Times ran a feature on Adrian Cardenas, a former major league baseball player who is now studying philosophy and creating writing at NYU.

NYU Footer